Implementing a serialization program?

Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.   Learn More »

Regulatory

Katherine Eban
May 20, 2013 | Column/Opinion

Special report: Dirty medicine

Katherine Eban's epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
Sample codes for UDI story
May 17, 2013 | Column/Opinion

UDI: Bane or benefit? You decide

Packaging and labeling professionals may be best prepared to help their organizations navigate Unique Device Identification.
Jim Chrzan, Healthcare Packaging Publisher
May 9, 2013 | Column/Opinion

Could federal bills supersede California's e-pedigree?

Pending legislation would only address pharmaceutical lot-level track and trace, according to this report from the Global Track & Trace Roundtable in NJ.
Eric Greenberg
May 3, 2013 | Column/Opinion

FDA has wish list on regulating compounders

Congress might be listening as quality control issues at compounders cause health-related death and illness.
Newly-opened US commercial packaging facility
May 1, 2013 | Video

Newly-opened US commercial packaging facility

Customer demand encourages Almac to open a US commercial packaging facility for bottling, blistering, vial labeling, kitting and walleting.
Too much medication?
April 24, 2013 | News

Report says 40% of parents give young kids cough/cold medicine that they shouldn’t

Many parents disregard label warnings. …Meanwhile, FDA’s BeSafeRx provides interactive map tool to protect against fake pharmaceuticals.
Purdue OxyContin
April 23, 2013 | News

Purdue Pharma receives FDA approval for OxyContin label language

New language describes abuse-deterrence studies conducted with reformulated tablets. Agency will not approve generics to original OxyContin.
April 2013 HCP Cover
April 3, 2013 | Feature Article

Combination products: The future of medicine

The advancement of exciting medical treatments depends in large part on education and communication.
Pills on money background
March 28, 2013 | Column/Opinion

'Reverse settlements' case heard in the U.S. Supreme Court

FTC argues 'pay-to-delay' agreements by brand-name pharmaceutical firms to generic producers violate antitrust laws; decision expected by June.
Desmond Hunt
March 1, 2013 | Column/Opinion

Pending USP revisions to packaging and moisture permeation chapters

Dr. Desmond G. Hunt, senior scientific liaison within the U.S. Pharmacopoeial Convention (USP), discusses USP’s pending revisions to USP General Chapter <671> Containers—Performance Testing, concerning packaging and moisture permeation.

Pages

Subscribe to Regulatory
Newsletters
Don’t miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!

GENERAL INTEREST

Breaking packaging news

Pertinent packaging issues

PACKAGE DESIGN/ DEVELOPMENT

Sustainable packaging

Package design strategies

HEALTHCARE

PACKAGING MACHINERY

Keith Campbell speaks out!

New packaging machines

PACK EXPO

PLAYBOOK STRATEGIES

FROM SISTER PUBLICATION AUTOMATION WORLD

Industry Trends & Applications

Each newsletter ranges in frequency from once per month to a few times per month at most.